| Edward James Donnelly Iii, R PH | |
|
1495 Old York Rd, Abington, PA 19001-1923 | |
| (215) 572-8085 | |
| (215) 572-8085 |
| Full Name | Edward James Donnelly Iii |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1495 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093945107 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP030003L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Edward James Donnelly Iii, R PH 1495 Old York Rd, Abington, PA 19001-1923 Ph: (215) 572-8085 | Edward James Donnelly Iii, R PH 1495 Old York Rd, Abington, PA 19001-1923 Ph: (215) 572-8085 |
News Archive
The journal Lancet Infectious Diseases examines the worldwide spread of extensively drug-resistant tuberculosis (XDR-TB). Currently, about 500,000 of the 9 million new cases of TB that are identified each year are strains of XDR-TB. "Drug resistance is largely man-made - it is vitally important to review antibiotic treatment strategies and to ensure the Stop TB Strategy is fully applied to prevent further selection of drug-resistant mutants," Leonard Amaral of Universidade Nova de Lisboa said.
Ethiopia's government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over a six-month period in 2009, of people in 53 villages across three regions of the country, according to an HRW press release (10/19).
Scientists at the University of Utah (U of U), the University of Texas MD Anderson Cancer Center in Houston and colleagues have developed a powerful tool called pVAAST that combines linkage analysis with case control association to help researchers and clinicians identify disease-causing mutations in families faster and more precisely than ever before.
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
› Verified 9 days ago
Matthew Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1495 Old York Rd, Abington, PA 19001 Phone: 215-572-8085 | |
Maya El Khansa, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1460 Old York Rd, Abington, PA 19001 Phone: 215-884-2767 | |
Mrs. Athina Bazalekos, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1441 Old York Rd, Abington, PA 19001 Phone: 215-886-0472 Fax: 215-886-9748 | |
Mr. Jeffrey S Budin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1460 Old York Rd, Abington, PA 19001 Phone: 215-884-2767 Fax: 215-884-0327 | |
Joke Itabiyi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 Highland Ave, Abington, PA 19001 Phone: 347-965-2829 | |
Kimberly Rinella, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1245 Highland Ave, Abington, PA 19001 Phone: 215-481-4319 |